title: Sphingomyelinase activity of LDL: a link between atherosclerosis, ceramide, and apoptosis?
abstract: Atherosclerosis is characterized by the accumulation in the arterial intima of mainly low-density lipoprotein (LDL)-derived lipids, together with apolipoprotein B-100 (apoB-100), the protein moiety of LDL. Recent studies indicate aggregation of LDL within the arterial wall to represent a critical step in the initiation of this disease. Aggregation of LDL has been further proposed to involve ceramide, the levels of which are elevated in atherosclerotic plaques as well as in LDL isolated from these lesions. Biophysical studies have shown ceramide to have a pronounced tendency for self-aggregation, presumably driven by intermolecular hydrogen bonding. Importantly, the segregated ceramide-enriched lipid phases have high melting temperatures and are in a gel state at 37 degrees C. The plasma levels of sphingomyelin, which upon enzymatic hydrolysis by sphingomyelinase (SMase) yields ceramide, have been shown to correlate with the severity of coronary heart disease. The formation of ceramide from sphingomyelin could thus represent a critical step in atherosclerosis. We recently showed that LDL itself possesses SMase activity. Moreover, sequence analogy with bacterial enzymes suggests that this activity may be intrinsic to apoB-100. Possible physiological role of this activity is uncertain, yet could be involved in nonreceptor-mediated endocytotic entry of LDL into cells. Importantly, it also opens a possible mechanistic link between elevated plasma levels of LDL, apoptosis (programmed cell death), and atherosclerosis.
authors.affiliation: Helsinki Biophysics & Biomembrane Group, Institute of Biomedicine, University of Helsinki, Helsinki, Finland. Paavo.Kinnunen@Helsinki.Fi
authors.forename: Paavo K J
authors.initials: PK
authors.lastname: Kinnunen
authors.forename: Juha M
authors.initials: JM
authors.lastname: Holopainen
mesh_terms: D017209:Apoptosis / Q000502:physiology*; D001161:Arteriosclerosis / Q000209:etiology / Q000378:metabolism*; D002518:Ceramides / Q000378:metabolism*; D006801:Humans; D008077:Lipoproteins, LDL / Q000378:metabolism*; D013108:Sphingomyelin Phosphodiesterase / Q000378:metabolism*; D013109:Sphingomyelins / Q000378:metabolism
chemical_list: D002518:Ceramides; D008077:Lipoproteins, LDL; D013109:Sphingomyelins; D013108:Sphingomyelin Phosphodiesterase